Global PET Radiopharmaceuticals Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global PET Radiopharmaceuticals Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for PET Radiopharmaceuticals by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for PET Radiopharmaceuticals by Country/Region, 2017, 2022 & 2028

2.2 PET Radiopharmaceuticals Segment by Type

2.2.1 F-18

2.2.2 Ru-82

2.2.3 Others

2.3 PET Radiopharmaceuticals Sales by Type

2.3.1 Global PET Radiopharmaceuticals Sales Market Share by Type (2017-2022)

2.3.2 Global PET Radiopharmaceuticals Revenue and Market Share by Type (2017-2022)

2.3.3 Global PET Radiopharmaceuticals Sale Price by Type (2017-2022)

2.4 PET Radiopharmaceuticals Segment by Application

2.4.1 Oncology

2.4.2 Cardiology

2.4.3 Neurology

2.4.4 Others

2.5 PET Radiopharmaceuticals Sales by Application

2.5.1 Global PET Radiopharmaceuticals Sale Market Share by Application (2017-2022)

2.5.2 Global PET Radiopharmaceuticals Revenue and Market Share by Application (2017-2022)

2.5.3 Global PET Radiopharmaceuticals Sale Price by Application (2017-2022)

3 Global PET Radiopharmaceuticals by Company

3.1 Global PET Radiopharmaceuticals Breakdown Data by Company

3.1.1 Global PET Radiopharmaceuticals Annual Sales by Company (2020-2022)

3.1.2 Global PET Radiopharmaceuticals Sales Market Share by Company (2020-2022)

3.2 Global PET Radiopharmaceuticals Annual Revenue by Company (2020-2022)

3.2.1 Global PET Radiopharmaceuticals Revenue by Company (2020-2022)

3.2.2 Global PET Radiopharmaceuticals Revenue Market Share by Company (2020-2022)

3.3 Global PET Radiopharmaceuticals Sale Price by Company

3.4 Key Manufacturers PET Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers PET Radiopharmaceuticals Product Location Distribution

3.4.2 Players PET Radiopharmaceuticals Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for PET Radiopharmaceuticals by Geographic Region

4.1 World Historic PET Radiopharmaceuticals Market Size by Geographic Region (2017-2022)

4.1.1 Global PET Radiopharmaceuticals Annual Sales by Geographic Region (2017-2022)

4.1.2 Global PET Radiopharmaceuticals Annual Revenue by Geographic Region

4.2 World Historic PET Radiopharmaceuticals Market Size by Country/Region (2017-2022)

4.2.1 Global PET Radiopharmaceuticals Annual Sales by Country/Region (2017-2022)

4.2.2 Global PET Radiopharmaceuticals Annual Revenue by Country/Region

4.3 Americas PET Radiopharmaceuticals Sales Growth

4.4 APAC PET Radiopharmaceuticals Sales Growth

4.5 Europe PET Radiopharmaceuticals Sales Growth

4.6 Middle East & Africa PET Radiopharmaceuticals Sales Growth

5 Americas

5.1 Americas PET Radiopharmaceuticals Sales by Country

5.1.1 Americas PET Radiopharmaceuticals Sales by Country (2017-2022)

5.1.2 Americas PET Radiopharmaceuticals Revenue by Country (2017-2022)

5.2 Americas PET Radiopharmaceuticals Sales by Type

5.3 Americas PET Radiopharmaceuticals Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC PET Radiopharmaceuticals Sales by Region

6.1.1 APAC PET Radiopharmaceuticals Sales by Region (2017-2022)

6.1.2 APAC PET Radiopharmaceuticals Revenue by Region (2017-2022)

6.2 APAC PET Radiopharmaceuticals Sales by Type

6.3 APAC PET Radiopharmaceuticals Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe PET Radiopharmaceuticals by Country

7.1.1 Europe PET Radiopharmaceuticals Sales by Country (2017-2022)

7.1.2 Europe PET Radiopharmaceuticals Revenue by Country (2017-2022)

7.2 Europe PET Radiopharmaceuticals Sales by Type

7.3 Europe PET Radiopharmaceuticals Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa PET Radiopharmaceuticals by Country

8.1.1 Middle East & Africa PET Radiopharmaceuticals Sales by Country (2017-2022)

8.1.2 Middle East & Africa PET Radiopharmaceuticals Revenue by Country (2017-2022)

8.2 Middle East & Africa PET Radiopharmaceuticals Sales by Type

8.3 Middle East & Africa PET Radiopharmaceuticals Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of PET Radiopharmaceuticals

10.3 Manufacturing Process Analysis of PET Radiopharmaceuticals

10.4 Industry Chain Structure of PET Radiopharmaceuticals

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 PET Radiopharmaceuticals Distributors

11.3 PET Radiopharmaceuticals Customer

12 World Forecast Review for PET Radiopharmaceuticals by Geographic Region

12.1 Global PET Radiopharmaceuticals Market Size Forecast by Region

12.1.1 Global PET Radiopharmaceuticals Forecast by Region (2023-2028)

12.1.2 Global PET Radiopharmaceuticals Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global PET Radiopharmaceuticals Forecast by Type

12.7 Global PET Radiopharmaceuticals Forecast by Application

13 Key Players Analysis

13.1 Cardinal Health Inc. (U.S.)

13.1.1 Cardinal Health Inc. (U.S.) Company Information

13.1.2 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Offered

13.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Cardinal Health Inc. (U.S.) Main Business Overview

13.1.5 Cardinal Health Inc. (U.S.) Latest Developments

13.2 Mallinckrodt plc (Ireland)

13.2.1 Mallinckrodt plc (Ireland) Company Information

13.2.2 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Offered

13.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Mallinckrodt plc (Ireland) Main Business Overview

13.2.5 Mallinckrodt plc (Ireland) Latest Developments

13.3 GE Healthcare (U.K.)

13.3.1 GE Healthcare (U.K.) Company Information

13.3.2 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Offered

13.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GE Healthcare (U.K.) Main Business Overview

13.3.5 GE Healthcare (U.K.) Latest Developments

13.4 Lantheus Medical Imaging, Inc. (U.S.)

13.4.1 Lantheus Medical Imaging, Inc. (U.S.) Company Information

13.4.2 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Offered

13.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Lantheus Medical Imaging, Inc. (U.S.) Main Business Overview

13.4.5 Lantheus Medical Imaging, Inc. (U.S.) Latest Developments

13.5 Bayer AG (Germany)

13.5.1 Bayer AG (Germany) Company Information

13.5.2 Bayer AG (Germany) PET Radiopharmaceuticals Product Offered

13.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bayer AG (Germany) Main Business Overview

13.5.5 Bayer AG (Germany) Latest Developments

13.6 Bracco Imaging S.p.A (Italy)

13.6.1 Bracco Imaging S.p.A (Italy) Company Information

13.6.2 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Offered

13.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bracco Imaging S.p.A (Italy) Main Business Overview

13.6.5 Bracco Imaging S.p.A (Italy) Latest Developments

13.7 Eczacibasi-Monrol Nuclear Products (Turkey)

13.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Information

13.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Offered

13.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) Main Business Overview

13.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Latest Developments

13.8 Nordion, Inc. (Canada)

13.8.1 Nordion, Inc. (Canada) Company Information

13.8.2 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Offered

13.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Nordion, Inc. (Canada) Main Business Overview

13.8.5 Nordion, Inc. (Canada) Latest Developments

13.9 Advanced Accelerator Applications S.A. (France)

13.9.1 Advanced Accelerator Applications S.A. (France) Company Information

13.9.2 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Offered

13.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Advanced Accelerator Applications S.A. (France) Main Business Overview

13.9.5 Advanced Accelerator Applications S.A. (France) Latest Developments

13.10 IBA Molecular Imaging (Belgium)

13.10.1 IBA Molecular Imaging (Belgium) Company Information

13.10.2 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Offered

13.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 IBA Molecular Imaging (Belgium) Main Business Overview

13.10.5 IBA Molecular Imaging (Belgium) Latest Developments

14 Research Findings and Conclusion

Table 1. PET Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. PET Radiopharmaceuticals Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of F-18

Table 4. Major Players of Ru-82

Table 5. Major Players of Others

Table 6. Global PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)

Table 7. Global PET Radiopharmaceuticals Sales Market Share by Type (2017-2022)

Table 8. Global PET Radiopharmaceuticals Revenue by Type (2017-2022) & ($ million)

Table 9. Global PET Radiopharmaceuticals Revenue Market Share by Type (2017-2022)

Table 10. Global PET Radiopharmaceuticals Sale Price by Type (2017-2022) & (USD/Pcs)

Table 11. Global PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)

Table 12. Global PET Radiopharmaceuticals Sales Market Share by Application (2017-2022)

Table 13. Global PET Radiopharmaceuticals Revenue by Application (2017-2022)

Table 14. Global PET Radiopharmaceuticals Revenue Market Share by Application (2017-2022)

Table 15. Global PET Radiopharmaceuticals Sale Price by Application (2017-2022) & (USD/Pcs)

Table 16. Global PET Radiopharmaceuticals Sales by Company (2020-2022) & (K Pcs)

Table 17. Global PET Radiopharmaceuticals Sales Market Share by Company (2020-2022)

Table 18. Global PET Radiopharmaceuticals Revenue by Company (2020-2022) ($ Millions)

Table 19. Global PET Radiopharmaceuticals Revenue Market Share by Company (2020-2022)

Table 20. Global PET Radiopharmaceuticals Sale Price by Company (2020-2022) & (USD/Pcs)

Table 21. Key Manufacturers PET Radiopharmaceuticals Producing Area Distribution and Sales Area

Table 22. Players PET Radiopharmaceuticals Products Offered

Table 23. PET Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global PET Radiopharmaceuticals Sales by Geographic Region (2017-2022) & (K Pcs)

Table 27. Global PET Radiopharmaceuticals Sales Market Share Geographic Region (2017-2022)

Table 28. Global PET Radiopharmaceuticals Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global PET Radiopharmaceuticals Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global PET Radiopharmaceuticals Sales by Country/Region (2017-2022) & (K Pcs)

Table 31. Global PET Radiopharmaceuticals Sales Market Share by Country/Region (2017-2022)

Table 32. Global PET Radiopharmaceuticals Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global PET Radiopharmaceuticals Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas PET Radiopharmaceuticals Sales by Country (2017-2022) & (K Pcs)

Table 35. Americas PET Radiopharmaceuticals Sales Market Share by Country (2017-2022)

Table 36. Americas PET Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas PET Radiopharmaceuticals Revenue Market Share by Country (2017-2022)

Table 38. Americas PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)

Table 39. Americas PET Radiopharmaceuticals Sales Market Share by Type (2017-2022)

Table 40. Americas PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)

Table 41. Americas PET Radiopharmaceuticals Sales Market Share by Application (2017-2022)

Table 42. APAC PET Radiopharmaceuticals Sales by Region (2017-2022) & (K Pcs)

Table 43. APAC PET Radiopharmaceuticals Sales Market Share by Region (2017-2022)

Table 44. APAC PET Radiopharmaceuticals Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC PET Radiopharmaceuticals Revenue Market Share by Region (2017-2022)

Table 46. APAC PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)

Table 47. APAC PET Radiopharmaceuticals Sales Market Share by Type (2017-2022)

Table 48. APAC PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)

Table 49. APAC PET Radiopharmaceuticals Sales Market Share by Application (2017-2022)

Table 50. Europe PET Radiopharmaceuticals Sales by Country (2017-2022) & (K Pcs)

Table 51. Europe PET Radiopharmaceuticals Sales Market Share by Country (2017-2022)

Table 52. Europe PET Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe PET Radiopharmaceuticals Revenue Market Share by Country (2017-2022)

Table 54. Europe PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)

Table 55. Europe PET Radiopharmaceuticals Sales Market Share by Type (2017-2022)

Table 56. Europe PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)

Table 57. Europe PET Radiopharmaceuticals Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa PET Radiopharmaceuticals Sales by Country (2017-2022) & (K Pcs)

Table 59. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa PET Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa PET Radiopharmaceuticals Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)

Table 63. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)

Table 65. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of PET Radiopharmaceuticals

Table 67. Key Market Challenges & Risks of PET Radiopharmaceuticals

Table 68. Key Industry Trends of PET Radiopharmaceuticals

Table 69. PET Radiopharmaceuticals Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. PET Radiopharmaceuticals Distributors List

Table 72. PET Radiopharmaceuticals Customer List

Table 73. Global PET Radiopharmaceuticals Sales Forecast by Region (2023-2028) & (K Pcs)

Table 74. Global PET Radiopharmaceuticals Sales Market Forecast by Region

Table 75. Global PET Radiopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas PET Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Pcs)

Table 78. Americas PET Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC PET Radiopharmaceuticals Sales Forecast by Region (2023-2028) & (K Pcs)

Table 80. APAC PET Radiopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe PET Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Pcs)

Table 82. Europe PET Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa PET Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Middle East & Africa PET Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global PET Radiopharmaceuticals Sales Forecast by Type (2023-2028) & (K Pcs)

Table 86. Global PET Radiopharmaceuticals Sales Market Share Forecast by Type (2023-2028)

Table 87. Global PET Radiopharmaceuticals Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global PET Radiopharmaceuticals Sales Forecast by Application (2023-2028) & (K Pcs)

Table 90. Global PET Radiopharmaceuticals Sales Market Share Forecast by Application (2023-2028)

Table 91. Global PET Radiopharmaceuticals Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Application (2023-2028)

Table 93. Cardinal Health Inc. (U.S.) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 94. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Offered

Table 95. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 96. Cardinal Health Inc. (U.S.) Main Business

Table 97. Cardinal Health Inc. (U.S.) Latest Developments

Table 98. Mallinckrodt plc (Ireland) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 99. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Offered

Table 100. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 101. Mallinckrodt plc (Ireland) Main Business

Table 102. Mallinckrodt plc (Ireland) Latest Developments

Table 103. GE Healthcare (U.K.) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 104. GE Healthcare (U.K.) PET Radiopharmaceuticals Product Offered

Table 105. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 106. GE Healthcare (U.K.) Main Business

Table 107. GE Healthcare (U.K.) Latest Developments

Table 108. Lantheus Medical Imaging, Inc. (U.S.) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 109. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Offered

Table 110. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 111. Lantheus Medical Imaging, Inc. (U.S.) Main Business

Table 112. Lantheus Medical Imaging, Inc. (U.S.) Latest Developments

Table 113. Bayer AG (Germany) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 114. Bayer AG (Germany) PET Radiopharmaceuticals Product Offered

Table 115. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 116. Bayer AG (Germany) Main Business

Table 117. Bayer AG (Germany) Latest Developments

Table 118. Bracco Imaging S.p.A (Italy) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 119. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Offered

Table 120. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 121. Bracco Imaging S.p.A (Italy) Main Business

Table 122. Bracco Imaging S.p.A (Italy) Latest Developments

Table 123. Eczacibasi-Monrol Nuclear Products (Turkey) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 124. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Offered

Table 125. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 126. Eczacibasi-Monrol Nuclear Products (Turkey) Main Business

Table 127. Eczacibasi-Monrol Nuclear Products (Turkey) Latest Developments

Table 128. Nordion, Inc. (Canada) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 129. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Offered

Table 130. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 131. Nordion, Inc. (Canada) Main Business

Table 132. Nordion, Inc. (Canada) Latest Developments

Table 133. Advanced Accelerator Applications S.A. (France) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 134. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Offered

Table 135. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 136. Advanced Accelerator Applications S.A. (France) Main Business

Table 137. Advanced Accelerator Applications S.A. (France) Latest Developments

Table 138. IBA Molecular Imaging (Belgium) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 139. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Offered

Table 140. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 141. IBA Molecular Imaging (Belgium) Main Business

Table 142. IBA Molecular Imaging (Belgium) Latest Developments

List of Figures

Figure 1. Picture of PET Radiopharmaceuticals

Figure 2. PET Radiopharmaceuticals Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global PET Radiopharmaceuticals Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global PET Radiopharmaceuticals Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. PET Radiopharmaceuticals Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of F-18

Figure 10. Product Picture of Ru-82

Figure 11. Product Picture of Others

Figure 12. Global PET Radiopharmaceuticals Sales Market Share by Type in 2021

Figure 13. Global PET Radiopharmaceuticals Revenue Market Share by Type (2017-2022)

Figure 14. PET Radiopharmaceuticals Consumed in Oncology

Figure 15. Global PET Radiopharmaceuticals Market: Oncology (2017-2022) & (K Pcs)

Figure 16. PET Radiopharmaceuticals Consumed in Cardiology

Figure 17. Global PET Radiopharmaceuticals Market: Cardiology (2017-2022) & (K Pcs)

Figure 18. PET Radiopharmaceuticals Consumed in Neurology

Figure 19. Global PET Radiopharmaceuticals Market: Neurology (2017-2022) & (K Pcs)

Figure 20. PET Radiopharmaceuticals Consumed in Others

Figure 21. Global PET Radiopharmaceuticals Market: Others (2017-2022) & (K Pcs)

Figure 22. Global PET Radiopharmaceuticals Sales Market Share by Application (2017-2022)

Figure 23. Global PET Radiopharmaceuticals Revenue Market Share by Application in 2021

Figure 24. PET Radiopharmaceuticals Revenue Market by Company in 2021 ($ Million)

Figure 25. Global PET Radiopharmaceuticals Revenue Market Share by Company in 2021

Figure 26. Global PET Radiopharmaceuticals Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global PET Radiopharmaceuticals Revenue Market Share by Geographic Region in 2021

Figure 28. Global PET Radiopharmaceuticals Sales Market Share by Region (2017-2022)

Figure 29. Global PET Radiopharmaceuticals Revenue Market Share by Country/Region in 2021

Figure 30. Americas PET Radiopharmaceuticals Sales 2017-2022 (K Pcs)

Figure 31. Americas PET Radiopharmaceuticals Revenue 2017-2022 ($ Millions)

Figure 32. APAC PET Radiopharmaceuticals Sales 2017-2022 (K Pcs)

Figure 33. APAC PET Radiopharmaceuticals Revenue 2017-2022 ($ Millions)

Figure 34. Europe PET Radiopharmaceuticals Sales 2017-2022 (K Pcs)

Figure 35. Europe PET Radiopharmaceuticals Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa PET Radiopharmaceuticals Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa PET Radiopharmaceuticals Revenue 2017-2022 ($ Millions)

Figure 38. Americas PET Radiopharmaceuticals Sales Market Share by Country in 2021

Figure 39. Americas PET Radiopharmaceuticals Revenue Market Share by Country in 2021

Figure 40. United States PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC PET Radiopharmaceuticals Sales Market Share by Region in 2021

Figure 45. APAC PET Radiopharmaceuticals Revenue Market Share by Regions in 2021

Figure 46. China PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 50. India PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe PET Radiopharmaceuticals Sales Market Share by Country in 2021

Figure 53. Europe PET Radiopharmaceuticals Revenue Market Share by Country in 2021

Figure 54. Germany PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 55. France PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Country in 2021

Figure 60. Middle East & Africa PET Radiopharmaceuticals Revenue Market Share by Country in 2021

Figure 61. Egypt PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of PET Radiopharmaceuticals in 2021

Figure 67. Manufacturing Process Analysis of PET Radiopharmaceuticals

Figure 68. Industry Chain Structure of PET Radiopharmaceuticals

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles